Evidence for the participation of the nitric oxide-cyclic GMP pathway in the antinociceptive effect of nimesulide - PubMed

Evidence for the participation of the nitric oxide-cyclic GMP pathway in the antinociceptive effect of nimesulide

M Islas-Cadena et al. J Pharmacol Toxicol Methods. 1999 Oct.

Abstract

The involvement of the nitric oxide-cyclic GMP pathway in the peripheral antinociception induced by the COX-2 preferential inhibitor nimesulide was assessed by using the formalin test in the rat. Intraplantar administration of nimesulide in the formalin-injured paw produced a significant antinociceptive effect that was due to a local action, because nimesulide administration in the contralateral paw was ineffective. Local pretreatment of the paws with saline or N(G)-D-nitro-arginine methyl ester (D-NAME, the inactive isomer of L-NAME) did not affect the antinociception produced by nimesulide. However, local administration of L-NAME (a nitric oxide synthesis inhibitor) or 1H-(1,2,4)-oxadiazolo(4, 2-a)quinoxalin-1-one (ODQ, a soluble guanylyl cyclase inhibitor) blocked the effect of nimesulide. Moreover, the antinociceptive effect of local nimesulide was potentiated by the coadministration of 3-morpholino-sydnonimine-HCl (SIN-1, a nitric oxide donor). It is concluded that nimesulide produces antinociception by a peripheral mechanism of action requiring activation of the nitric oxide-cyclic GMP pathway at the local level.

Similar articles

• Evidence for the participation of the nitric oxide-cyclic GMP pathway in the antinociceptive action of meloxicam in the formalin test.

  Aguirre-Bañuelos P, Granados-Soto V. Aguirre-Bañuelos P, et al. Eur J Pharmacol. 2000 Apr 21;395(1):9-13. doi: 10.1016/s0014-2999(00)00157-6. Eur J Pharmacol. 2000. PMID: 10781667

• Participation of the nitric oxide-cyclic GMP-ATP-sensitive K(+) channel pathway in the antinociceptive action of ketorolac.

  Lázaro-Ibáñez GG, Torres-López JE, Granados-Soto V. Lázaro-Ibáñez GG, et al. Eur J Pharmacol. 2001 Aug 24;426(1-2):39-44. doi: 10.1016/s0014-2999(01)01206-7. Eur J Pharmacol. 2001. PMID: 11525769

• Possible participation of the nitric oxide-cyclic GMP-protein kinase G-K+ channels pathway in the peripheral antinociception of melatonin.

  Hernández-Pacheco A, Araiza-Saldaña CI, Granados-Soto V, Mixcoatl-Zecuatl T. Hernández-Pacheco A, et al. Eur J Pharmacol. 2008 Oct 31;596(1-3):70-6. doi: 10.1016/j.ejphar.2008.07.068. Epub 2008 Aug 13. Eur J Pharmacol. 2008. PMID: 18755181

• The in vivo assessment of nimesulide cyclooxygenase-2 selectivity.

  Shah AA, Murray FE, Fitzgerald DJ. Shah AA, et al. Rheumatology (Oxford). 1999 May;38 Suppl 1:19-23. doi: 10.1093/rheumatology/38.suppl_1.19. Rheumatology (Oxford). 1999. PMID: 10369402 Review.

• Overview of nimesulide.

  Bennett A. Bennett A. Rheumatology (Oxford). 1999 May;38 Suppl 1:1-3. doi: 10.1093/rheumatology/38.suppl_1.1. Rheumatology (Oxford). 1999. PMID: 10369398 Review. No abstract available.

Cited by

• Central components of the analgesic/antihyperalgesic effect of nimesulide: studies in animal models of pain and hyperalgesia.

  Tassorelli C, Greco R, Sandrini G, Nappi G. Tassorelli C, et al. Drugs. 2003;63 Suppl 1:9-22. doi: 10.2165/00003495-200363001-00003. Drugs. 2003. PMID: 14506907 Clinical Trial.

• The Role of Single-Nucleotide Variants of NOS1, NOS2, and NOS3 Genes in the Comorbidity of Arterial Hypertension and Tension-Type Headache.

  Shnayder NA, Petrova MM, Moskaleva PV, Shesternya PA, Pozhilenkova EA, Nasyrova RF. Shnayder NA, et al. Molecules. 2021 Mar 12;26(6):1556. doi: 10.3390/molecules26061556. Molecules. 2021. PMID: 33809023 Free PMC article. Review.

• Mechanisms of non-opioid analgesics beyond cyclooxygenase enzyme inhibition.

  Hamza M, Dionne RA. Hamza M, et al. Curr Mol Pharmacol. 2009 Jan;2(1):1-14. doi: 10.2174/1874467210902010001. Curr Mol Pharmacol. 2009. PMID: 19779578 Free PMC article. Review.

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Research Materials

  • NCI CPTC Antibody Characterization Program